- Filed
- May 7, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 5, 2020 | 34.29M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $1.43M |
| Capex | Q1 2020 · Mar 31, 2019 | $111K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$8.66M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | −$10.34M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $65.6M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $55.62M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $83.18M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $72.3M |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | $58.47M |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | $61.14M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $6.88M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $9.67M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $9.6M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $12.59M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $71.27M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $63.76M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $92.78M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $84.89M |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $4.73M |
| Sga Expense restated | Q1 2020 · Mar 31, 2019 | $4.54M |
| Rd Expense | Q1 2020 · Mar 31, 2020 | $5.81M |
| Rd Expense restated | Q1 2020 · Mar 31, 2019 | $7.88M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$10.15M |
| Net Income restated | Q1 2020 · Mar 31, 2019 | −$6.06M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$10.2M |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | −$6.13M |
| Gross Profit | Q1 2020 · Mar 31, 2020 | $342K |
| Gross Profit restated | Q1 2020 · Mar 31, 2019 | $6.3M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $340K |
| Cost Of Revenue restated | Q1 2020 · Mar 31, 2019 | $1.57M |
| Revenue | Q1 2020 · Mar 31, 2020 | $682K |
| Revenue | Q1 2020 · Mar 31, 2019 | $7.86M |